Soft Tissue Infections Clinical Trials

A listing of Soft Tissue Infections medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Buena Park California 90620

A clinical trial seeking patients for a research study for the treatment of Skin Structures and Soft Tissue Infections

Buena Park California 90620

A clinical trial to evaluate treatments using Iclaprim and Vancomycin for patients with Skin Structures and Soft Tissue Infections

Long Beach California 90813

A clinical trial to evaluate treatments using Iclaprim and Vancomycin for patients with Skin Structures and Soft Tissue Infections

Sacramento California 95817

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Torrance California 90503

A clinical trial seeking patients for a research study for the treatment of Skin Structures and Soft Tissue Infections

Colorado

Denver Colorado 80045

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Denver Colorado 80204

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Connecticut

New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Delaware

Newark Delaware 19718

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

District of Columbia

Washington District of Columbia 20010

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Florida

Miami Florida 33136

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Illinois

Maywood Illinois 60153

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Indiana

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Kentucky

Lexington Kentucky 40536

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Louisiana

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Maryland

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Massachusetts

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Boston Massachusetts 02118

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Minnesota

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Missouri

Columbia Missouri 65211

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

New Jersey

Camden New Jersey 08103

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Somers Point New Jersey 8244

A clinical trial to evaluate treatments using Iclaprim and Vancomycin for patients with Skin Structures and Soft Tissue Infections

North Carolina

Charlotte North Carolina 28208

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Durham North Carolina 27710

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Greenville North Carolina 27834

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Ohio

Columbus Ohio 43210

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Dayton Ohio 45409

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Youngstown Ohio 44501

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Oklahoma

Oklahoma City Oklahoma 73104

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Pennsylvania

Bethlehem Pennsylvania 18015

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Pittsburgh Pennsylvania 15213

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Texas

Dallas Texas 75390

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Fort Worth Texas 76104

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

McAllen Texas 78503

A clinical trial seeking patients for a research study for the treatment of Skin Structures and Soft Tissue Infections

San Antonio Texas 78229

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Virginia

Richmond Virginia 23298

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Washington

Kennewick Washington 99336

A clinical trial to evaluate treatments using Iclaprim and Vancomycin for patients with Skin Structures and Soft Tissue Infections

Seattle Washington 98104

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Japan

UPDATED

Amagasaki Hyogo 660-8511

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

UPDATED

Fukuoka 810-0001

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

UPDATED

Gifu 500-8513

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

UPDATED

Hamamatsu Shizuoka 430-0929

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

UPDATED

Inashiki-gun Ibaraki 300-0395

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

View More ▼

UPDATED

Iwata Shizuoka 438-8550

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

UPDATED

Kamakura Kanagawa 247-8533

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

UPDATED

Kasuga Fukuoka 816-0864

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious

UPDATED

Kitakyushu Fukuoka 802-0077

Patients are needed to participate in a clinical research study of Tedizolid(BAY1192631) and Linezolid to evaluate Skin Diseases, Infectious